What is EW's health score?

Edwards Lifesciences Corp (EW) has a TradeApes health score of 72 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is EW's estimated fair value?

Based on our 5-year discounted cash flow model, Edwards Lifesciences Corp's estimated fair value is $18.06 per share, representing a -79.0% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is EW undervalued or overvalued?

Our model currently rates EW as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for EW... Refresh in a moment for the full analysis.

Edwards Lifesciences Corp (EW)

Healthcare Overvalued low healthy

$86.0

Updated: 2026-06-04

TradeApes Score

Financial Strength

90 Strong

Operating Trend

81 Strong

Relative Value

50 Mixed

Capital Allocation

55 Mixed

Risk

80 Strong

Est. Fair Value $18.06

DCF Upside -79.0%

Sector Rank #5376 of 6544

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.